Multiple Assemblies exist for SMTL entry 7fbj
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6; X-RAY DIFFRACTION 2.85 Å

	SMTL ID 7fbj.1 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Spike protein S1; New antigen receptor variable domain Oligo-state hetero-1-1-mer
	SMTL ID 7fbj.2 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Spike protein S1; New antigen receptor variable domain Oligo-state hetero-1-1-mer
	SMTL ID 7fbj.3 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Spike protein S1; New antigen receptor variable domain Oligo-state hetero-1-1-mer
	SMTL ID 7fbj.4 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Spike protein S1; New antigen receptor variable domain Oligo-state hetero-1-1-mer
	SMTL ID 7fbj.5 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Spike protein S1; New antigen receptor variable domain Oligo-state hetero-1-1-mer
	SMTL ID 7fbj.6 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Spike protein S1; New antigen receptor variable domain Oligo-state hetero-1-1-mer
	SMTL ID 7fbj.7 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Spike protein S1; New antigen receptor variable domain Oligo-state hetero-1-1-mer
	SMTL ID 7fbj.8 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Spike protein S1; New antigen receptor variable domain Oligo-state hetero-1-1-mer